Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops
Publication date:
2018Editorial:
Springer Science+Business Media B.V.
Publisher version:
http://dx.doi.org/10.1007/s10792-017-0582-7Citación:
International Ophthalmology, 38(3), p. 1193-1204 (2018); DOI: 10.1007/s10792-017-0582-7Descripción física:
1193-1204Patrocinado por
This study received funding from the Ministry of Economy and Competitiveness of the Spanish Government, within the project denominated SURFEYE (reference RTC-2014-2375-1)
Id. Proyecto
MINECO/RTC-2014-2375-1
Collections
- Artículos [27036]